Deborah Arnott is Chief Executive of Action on Smoking and Health (UK), honorary associate professor in the Division of Epidemiology and Public Health at the University of Nottingham, honorary fellow of the Royal College of Physicians and member of the RCP’s Tobacco Advisory Group. A recognised international expert on tobacco control and the WHO Framework Convention on Tobacco Control, she has a particular interest in nicotine regulation and harm reduction. She was a member of the NICE committee which developed the guidance on Tobacco Harm Reduction and of the Commission on Human Medicines expert advisory group to the MHRA on nicotine containing products, as well as being a civil society observer to the WHO FCTC Article 9 and 10 working group on tobacco product regulation. Previously Head of Consumer Education for the UK’s statutory financial services regulator, she also has experience as a journalist in print and television.
Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair's Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco. Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog. He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.
Linda Bauld is Professor of Health Policy, Director of the Institute for Social Marketing and Dean of Research (Impact) at the University of Stirling in Scotland. She is also Deputy Director of the UK Centre for Tobacco and Alcohol Studies and holds the CRUK/BUPA Chair in Behavioural Research for Cancer Prevention at Cancer Research UK. She has conducted research on smoking cessation and tobacco control for 20 years, is a former UK government scientific advisor on tobacco control and chaired the NICE guidance group on tobacco harm reduction. Linda is Deputy Editor of the journal Nicotine and Tobacco Research and President-Elect of the Society for Research on Nicotine and Tobacco Europe. In 2017 she was elected a Fellow of the Royal College of Physicians of Edinburgh for her contribution to public health and cancer prevention.
Peter Beckett is a consultant who specialises in the identification, analysis and management of political risk. He spent nearly three years as Head of Public Policy for ECITA, where he was responsible for industry-level political advocacy during the procedure that led to the passage of the Tobacco Products Directive. He has also been instrumental in its implementation, is an expert in compliance with its requirements and was at the centre of negotiations that led to the formation of CEN TC 437 on electronic cigarettes and e-liquids. He also works with the US Vapor Technology Association, advocating for sensible regulations in North America, and consults for leading nicotine delivery companies around the world.
Atakan Erik Befrits is a Turkish/Swedish tobacco harm reduction advocate, policy researcher and harm reduction entrepreneur. Mr Befrits works for the global recognition and adoption of tobacco harm reduction as a vital and crucial tool for better public health and argues that tobacco harm reduction is clearly stipulated as mandatory in the Framework Convention on Tobacco Control. His primary area of advocacy is to internationally provide information on food grade smokeless tobacco (aka snus or snus-analog products) being viable, affordable and 98% harm reduced alternatives to smoking.
Neal L. Benowitz, MD, is Professor of Medicine and Bioengineering & Therapeutic Sciences, and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco (UCSF). He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974. His research interests have focused primarily on the human pharmacology and toxicology of nicotine. He has published more than 600 research papers. Dr Benowitz also maintains an active clinical practice in cardiovascular medicine and medical toxicology.
John Boley has a background in journalism. An experienced TV/video presenter, producer and writer, he has worked on a wide range of contentious issues, including vehicle emissions and sustainability in Asia's tourism industry. Based in Asia for 20 years, he co-founded FactAsia with Heneage Mitchell in 2012 as both saw issues increasingly misrepresented and consumer rights trampled on.
Ron Borland PhD is the Nigel Gray Distinguished Fellow in Cancer Prevention, at The Cancer Council Victoria, Australia where he has worked for 30 years. He is listed in the Thomson-Reuters List of the World’s most influential scientists. He is one of the Principal Investigators of the International Tobacco Control Policy Evaluation Project: an international collaboration that is analysing the impact of policies on smoking. His has a special interest in harm minimisation strategies and strategies to assist highly disadvantaged, high smoking prevalence groups. He is the developer of CEOS theory: a comprehensive theory of Hard to Maintain Behaviour Change.
Cynthia Cabrera is a seasoned expert in the vapor space,involved in the vapor industry since 2011. As Founder and president of The Cating Group, Cynthia and her team provide business-consulting services including compliance, manufacturing operations, restructuring, government affairs, and business development including new product rollout and strategic partnerships. She is a frequent speaker on trends, product evolvement, distribution channels, and regulatory and legislative issues. Cynthia has presented for The Tobacco Merchants Association (TMA), The Global Tobacco Nicotine Forum (GTNF), the Global Forum on Nicotine (GFN), The Food & Drug Law Institute (FDLI,), The Responsible Retailers Forum (RRF), ECIG USA, the Morven Dialogues and a wide variety of vapor shows and exhibits.
Jeannie Cameron is founder and managing director of JCIC International Ltd; a UK based strategic advocacy consultancy specializing in tobacco harm reduction, anti-illicit trade and supply-chain security. For 10 years until 2011 Jeannie was responsible for worldwide advice on all aspects of the FCTC treaty and Protocol including leading delegations to Geneva negotiations and is a known FCTC expert. In 2007 Jeannie received a distinction for her Masters in Law (LLM) dissertation: Emerging International Public Health Issues – Human Rights, Harm Reduction and the Framework Convention on Tobacco Control (FCTC), and continues to advocate about the legal basis on which the FCTC requires Parties to implement harm reduction strategies as part of national tobacco control policies.
Martin Cawley joined the Big Lottery Fund in September as Director for Scotland following a successful period as chief executive of Turning Point Scotland. Martin has worked in practitioner, management and leadership positions in both the statutory and voluntary sectors for over 34 years. Martin has extensive experience of developing and managing person centered services designed to support people achieve full and active citizenship. Over the years he has also been a board member of a number of smaller organisations including national umbrella agencies and social enterprises aimed at improving practice and approach and influencing social policy. Martin is a huge fan of all kinds of sports and enjoys participating in one or two every now and again. He also loves travelling and spending time with his family.
Dr Sharon Cox has over ten years’ experience working in the drug and alcohol field, including working at front-line services with some of the UK's most deprived communities. She has a special interest in harm-reduction and advocates for improving lives through transparency and opportunity. She currently works as a Cancer Research UK Funded Research Fellow at London South Bank University's Centre for Addictive Behaviour Research. Her current research is focused on e-cigarette puffing patterns associated with high and low nicotine e-liquid strength, effects on toxicant and carcinogen exposure.
Dr Attila Danko is an experienced, busy General Practitioner in Ballarat, a regional city in Australia. Over the last few years, several of his patients have surprised him by being able to give up smoking using electronic cigarettes when all other methods had failed. Inspired by the potential revolution in smoking cessation this represents, and appalled by the prohibitionist policies of his country, he began to advocate for the liberalisation of laws in Australia that effectively ban nicotine containing electronic cigarettes. He recieves no payment or any inducement whatsoever from any Pharmaceutical, Tobacco or Electronic cigarette company. He is in the preliminary stages of working with Professor Ron Borland, Nigel Gray Distinguished Fellow in Cancer Prevention at Cancer Council Victoria, Australia, on an upcoming study on electronic cigarettes.
Martin Dockrell has been involved in public health since the mid 1980's. He started in community based responses to HIV/AIDS and moved through respiratory health and patient advocacy to tobacco control. He is former Director of Policy & Research at Action on Smoking and Health.
Dr. Eric C. Donny is a Professor of Psychology, Psychiatry and Behavioral & Community Health Sciences at the University of Pittsburgh. His expertise includes behavioral pharmacology, biological and health psychology, addiction, and regulatory science. His current interests focus on regulatory approaches to reducing the health burden of tobacco. He co-directs the Center for the Evaluation of Nicotine in Cigarettes (CENIC), an NIDA/FDA-funded cooperative agreement that aims to increase understanding of how behavior and health might be affected if the nicotine content of combustible tobacco products is reduced.
Dr Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.
Dr. Marina Foltea is founder and Managing Director at Trade Pacts, a trade and investment consultancy based in Geneva, Switzerland and a researcher with R-Street Institute, Washington. Marina has obtained her Ph.D. in International Economic Law from the University of Bern, Switzerland. She was awarded the Walther Hug prize for the best legal dissertation in Switzerland and has published extensively in this field. Marina takes continuous keen interest on how international trade law interfaces with other fields of law and policy, in particular health and environment. She is frequent speaker in both academic and business related events. Since September 2016 she is on the Indicative List of WTO Panels, which makes her eligible to solve disputes between Member States at the World Trade Organisation in Geneva.
Since gaining her Brownie Wings in the 60’s, Judy Gibson has had an eclectic career including: WRAF Aircraft mechanic, drill instructor, restaurant manager, detective sergeant, MOD/MI5 gopher, Computer Consultant, twenty years in artiste management, theatre marketing/film programming and finally a Community Flood Consultant before reaching the zenith that is INNCO. A Jill of all trades and occasional mistress seems to cover it. A smoker since the invention of bike-sheds, Judy tried vaping about six years ago, reducing smoking but struggling with e-cigarette incarnations until, in 2015, technological improvements tipped the scales. Having finally eschewed cigarettes, she was astounded to discover that despite vaping being significantly safer, others were demanding draconian regulations and prohibition. Thus, a vociferous advocate for tobacco harm reduction was born. When not engaged in rebutting the latest vaping ‘research’ scare stories, overzealous state regulation or the latest calls for banning every e-liquid flavour except tobacco (the irony), she might be found nursing a large ‘Rakish Rhubarb Gin’, ambivalent to the rampaging brambles in her cottage garden.
Dr. Moira Gilchrist was appointed Vice President Reduced Risk Products Corporate Affairs in January 2017. Prior to this she was based in our R&D function where she was Director of Scientific Engagement from 2014 to 2016. Since joining PMI in 2006, Dr. Gilchrist has worked exclusively on our Reduced-Risk Product program in roles related to Research and Development as well as Commercialization. Prior to joining PMI, Dr. Gilchrist worked in the pharmaceutical sector for more than 10 years. She was a Principal Consultant in PwC and IBM’s pharmaceutical industry consulting groups and prior to that held positions in both industry and charity sectors developing new drug formulations. Dr. Gilchrist holds a degree in Pharmacy and a PhD. in Pharmaceutical Sciences, both from the University of Strathclyde in Glasgow, Scotland.
Joe Gitchell provides strategic counsel to clients across a wide range of health policy, regulatory, and marketing and communications challenges. With a focus on client service, Joe leads efforts supporting regulatory approvals, conducting public policy analysis, developing communications approaches, devising, refining and defending claims, and providing input on strategic market opportunities and directions. He has counseled clients navigating health policy and communications challenges in the US, Europe, Latin America, Asia and the Middle East.
Gillian Eva Golden comes from a background in the creative, customer service, and retail sectors. A former smoker thanks to discovering vaping in 2012, she now works as administrator for the Irish Vape Vendors Association, Ireland's only trade association for independently owned, specialised retailers of vaping products. She not only advocates for vaping as a means of tobacco harm reduction, but also for industry stewardship, and sits on the Technical Committee of CEN TC 437 for electronic cigarettes and e-liquids.
Charles Hamshaw-Thomas is the Head of Corporate and Legal Affairs for Europe at Nicopure Labs. Charlie was previously Corporate Affairs, Business Development and Legal Director for E-Lites, the brand at the forefront of the UK vaping industry’s explosive early growth beginning in 2012. Prior to that, he was Principal of CSR Solutions, a corporate social responsibility consultancy business. Having qualified as a lawyer in London with Slaughter and May, Charlie subsequently held senior management positions with some of the UK’s largest public companies (ITG, Beazer Homes, and Hanson Trust) where he has worked across different functional areas - including legal, m&a, company secretarial and corporate affairs — and in various markets throughout the world. Charlie is currently also Acting Secretary General for UKVIA (the UK Vaping Industry Association).
Jessica Harding became NNA’s first administrator in December 2016. She is passionate about the potential for tobacco harm reduction products to improve lives and has devoted much her time and energy to vaping consumer activism. She helped establish Vapers in Power, and helped to get ViP registered as a political party. Her primary role in NNA is fundraising, external communications, helping NNA campaigns, and supporting the work and development of NNA. Before having children she worked as an English teacher, in the UK and abroad.
Richard Holliday is a Speciality Registrar (StR) in Restorative Dentistry and NIHR Doctoral Research Fellow at Newcastle University. Richard’s research interests are focused on periodontal diseases, particularly risk factors, and he is currently completing his PhD on ‘e-cigarettes as a smoking cessation or harm reduction tool for patients with periodontitis’. The main body of this work is a feasibility randomised controlled trial of 80 smokers with periodontitis. Additional projects include surveys of tobacco education in UK dental schools, surveys of practitioner opinions and in vitro analysis.
Amelia Howard is a PhD candidate in Sociology at the University of Waterloo (Ontario, Canada). Her dissertation explores the social history of vapor technologies. Specifically, she is interested in the role played by "lead-users" in product innovation and in shaping the consumer market, the political and cultural dynamics of controversies surrounding the regulation of e-cigarettes, and the implications of various regulatory regimes for innovation and knowledge making practices in the vaping space. Amelia advocates for harm reduction policies that, in addition to making products available to consumers, recognize and protect users' ability to innovate in the market.
Michael Hufford has more than 20 years of experience in clinical research, drug and medical device development, and behavioral science across a wide range of therapeutic areas. He is currently Vice President of Regulatory Affairs, Behavioral Science and Innovation at Pinney Associates, and also an Entrepreneur in Residence at the University of Pittsburgh. Michael has co-founded multiple pharmaceutical, medical device, and mobile health companies, including of e-Nicotine Technology. Michael earned his undergraduate degree from Purdue University, and his master’s and doctoral degrees in clinical psychology from the University of Pittsburgh.
Since leaving school 'a very long time ago' Sarah Jakes has worked in the shipping industry, the foreign exchange market and now runs her own business in property management. A smoker of some 35 years Sarah switched to vaping in April 2013, only to find that the choice of this safer alternative for smokers was under threat from excessive and ill founded regulation. Having joined forces with other consumers in the battle against over regulation in the EU parliament Sarah is convinced that a better understanding of e-cigarettes and other harm reduced products among key influencers and decision makers is required if these products are ever to reach their full potential for public health gains.
Catherine Kimber is a Doctoral candidate at the School of Psychology at the University of East London. Her research is concerned with nicotine and smoking addiction with a focus on e-cigarette use. Earlier work looked at the relationship between e-cigarette types and their appeal to smokers. She has also been involved in other work which includes the effects of nicotine on smokers’ cognitive functioning. Her PhD is looking at compensatory behaviours in e-cigarette use, nicotine delivery and e-cigarettes’ efficacy as smoking cessation aids.
Cecilia Kindstrand is Director of Public Affairs for Swedish Match, a tobacco company with tobacco harm reduction at the core of its business. She is based in Brussels and has worked extensively with the revision of the EU’s Tobacco Products Directive, a legislation banning the ‘proof of concept’ of tobacco harm reduction in 27 of the 28 Member States. The vision of Swedish Match is A World Without Cigarettes.
Thomas R. Kirchner, PhD, is Clinical Associate Professor of Public Health, Medicine, and Urban Science at NYU, and founding director of NYU mobile health (mHealth). Dr. Kirchner is a clinical-health psychologist and methodologist interested in the analysis and graphical representation of “intensive” longitudinal and geographic data, including novel methodologies that link individual behavior to the real-time context in which it occurs. Dr. Kirchner’s approach targets momentary influences on the maintenance of addictive and health-related behavior utilizing both field-based (ecological momentary assessment) and laboratory-based paradigms. This includes development of novel analytical methods for the application of geographic information science (GIS) to public health and policy. Supported by funding from the US National Institute on Drug Abuse, US National Cancer Institute, and US NIH Office of Behavioral and Social Science Research, ongoing work focuses on the impact of emerging retail product landscapes on complex patterns of drug use, including the separate and combined use of tobacco and cannabis via both combusted and electronic drug delivery systems.
Patricia I. Kovacevic, Esq. is the General Counsel and Chief Compliance Officer of Nicopure Labs LLC. With extensive U.S. and international industry experience, Ms. Kovacevic held senior legal and compliance positions at, among other, Philip Morris International and Lorillard. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, compliance and all regulatory aspects of marketing/media communications, corporate affairs, criminal investigations, FCPA, trade sanctions, privacy, product development and launch. Ms. Kovacevic serves on the advisory board of the Global Tobacco and Nicotine Forum and on the board of the Vapor Technology Association, where Nicopure Labs is a founding member. In the past she was a United Nations staff member, served on UN's Public-Private Partnership Commission and was also an advisor to the Council for Burley Tobacco.
Peter Lee is an epidemiologist/medical statistician who has published widely, principally on tobacco. He went to Oxford, and after working for the Tobacco Research Council, formed his independent consultancy company P.N.Lee Statistics and Computing in 1982. He edited reference books on international smoking prevalence. He has published numerous meta-analyses on health effects, not only of smoking and quitting, but also of passive smoking and smokeless tobacco. Accuracy of diagnosis and self-reported smoking habits is a major interest. He has won national titles at both chess and bridge. He is married with one daughter and two grandchildren.
Involved in e-cigarette industry since 2012. Justyna Lipowicz is co-founder of the first Polish e-liquid on the Polish market in so-called serial production. Using more than 30 years of production experience, she manages a manufacturing enterprise which is one of the leading producers of liquids for electronic cigarettes on the Polish market. Justyna has been a speaker at trade events, among others, the Vape Expo Poland conference. She is also an active participant of the Global Forum on Nicotine and a member of the International Technical Committee CEN/TC 437, which is responsible for developing the European quality standard for "Electronic cigarettes and e-liquids". Justyna Lipowicz is a graduate of the Management Faculty at the Poznan University of Economics.
Dr. Thomas Mc Grath is Manager Reduced Risk Products (RRPs) at Philip Morris International (PMI). He joined PMI in 2005 and has worked in a variety of roles focused on the development, assessment and, most recently, commercialization of PMI’s RRPs. He has more than 10 years of experience working on research related to heating tobacco without combustion and has published a number of research articles on the formation of Polycyclic Aromatic Hydrocarbons (PAHs) and phenolic compounds. Dr. Mc Grath graduated from the University of Ulster, Northern Ireland with a first class honors degree in Science with Business and obtained his PhD in Chemistry from Brown University, Rhode Island, USA.
Kevin McGirr is Clinical Professor in the School of Nursing; has taught in schools of medicine, social work and public health and was a Fulbright Scholar in Pondicherry India, 2013-2014. He has over forty years experience in providing and managing behavioral health services; holds master’s degrees in public health, psychiatric nursing and ABD in public health. He has been involved in the training and development of harm reduction services and in particular utilizing Harm Reduction Tobacco interventions for persons with serious mental illness. He will present his recent qualitative investigation on the experience of tobacco interventions by persons with serious mental illness.
Colin Mendelsohn is an Associate Professor in the School of Public Health and Community Medicine at the University of New South Wales, Sydney, Australia. He is a medical practitioner and tobacco treatment specialist working in private practice. He is actively involved in raising awareness of the public health benefits of nicotine-containing e-cigarettes and advocating for their legalisation in Australia. His activities in the smoking cessation field include teaching medical students and health professionals, writing, research, public education and consulting to the pharmaceutical industry. Colin is a member of the committee that develops the Australian national smoking cessation guidelines and is past Vice President of the Australian Association of Smoking Cessation Professionals. Colin is on the steering committee of the QUIT4october stop smoking campaign.
Dr Joanna Astrid Miler is a Psychologist, with research interests in addiction, harm reduction and smoking cessation. Miler holds MA and MRes degrees from the University of St Andrews and a PhD from the University of Southampton. Prior to joining the Centre for Substance Use Research she worked as an Analyst at RAND Europe, and later, as a Research Health Psychologist in the Health and Lifestyle Research Unit of Queen Mary University of London. Alongside conducting scientific research, she is also a trained specialist stop smoking advisor and worked in that capacity for the City of London Stop Smoking Service.
Dr Caitlin Notley is a Senior Lecturer in Mental Health, and a Research Fellow of the UK Society for the Study of Addiction. She has more than ten years experience in Addiction research. Her current research focus is on tobacco smoking relapse prevention, and will develop an intervention to support women to stay abstinent from smoking postpartum. Dr Notley’s research interest in alternative nicotine delivery devices primarily explores social and culturally pertinent aspects of vaping, with a particular focus on the public health potential of vaping for smoking relapse prevention.
Dr David O'Reilly was appointed to the Management Board of British American Tobacco as Group Scientific and R&D Director, in January 2012. He graduated from Imperial College, London in 1991 with a Ph.D. in molecular virology. He continued to pursue this area of research when he joined Advanced Technologies Cambridge, a subsidiary of British American Tobacco, In recent years at BAT, O’Reilly has been a driving force behind the creation and growth of BAT’s multidisciplinary global R&D effort in consumer-led, science-based innovation in next-generation tobacco and nicotine products. He has also led the company’s programs in corporate social responsibility, tobacco harm reduction and scientific and public health policy and engagement. He is co-founder of the Global Tobacco and Nicotine Forum and Chairman emeritus of the GTNF Advisory Board.
Pat O'Hare was the Executive Director of Harm Reduction International from its founding in 1996 until he stepped down in 2004. He was then Honorary President of IHRA from 2004 until 2011, when he was elected to the board of directors of Harm Reduction International (HRI), the new name of IHRA. His work has taken him around the world to advocate for harm reduction approaches to the problems caused by drug use, especially those caused by the sharing of injecting equipment. He has edited three books on harm reduction and has published extensively on HIV prevention, education and drug policy, and has spoken at many international conferences.
Prof Riccardo Polosa is a director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University's Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books. On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa's and his research team have lead several clinical trials on e-cigarettes, for whose expertise he has been recently elected Convenor for the European Working Group on Requirements and test methods for emissions of electronic cigarettes, within the European Committee for Standardization (CEN/TC 437).
Lars Ramstrom since 1990 Director of the Institute for Tobacco Studies, Stockholm, Sweden, an independent research institute focusing on the epidemiology of tobacco use and related policy matters. From 1967 to 1989 Director of the National Smoking and Health Association, a governmentally supported NGO dealing with tobacco control matters. Originally trained in natural science, thereafter supplementary studies in different tobacco-related sciences. International engagements with various organizations including periods of employment as consultant in WHO, participation in WHO Expert Committees, member of the WHO Expert Advisory Panel on Smoking and Health, Honorary Vice President of ICAA (International Council on Alcohol and Addictions) and chair of the ICAA Section on nicotine. Recipient of the 1988 WHO Award Medal for Achievements in Tobacco Control. Organizer and Secretary General of the Fourth World Conference on Smoking and Health in 1979. Author of articles in the scientific literature and reviewer for a number of medical science journals.
Prof. Solomon Tshimong Rataemane: (President: African Psychiatric Association and Allied Professions 2014 – 2017). He is head of Department of Psychiatry, Sefako Makgatho Health Sciences University in South Africa; World Psychiatric Association (WPA) Board member and WPA Representative Zone 14 (2008 – 2014); and Chair of the WPA Section on Conflict Management and Conflict Resolution (2011 - 2018). He has special interest in addiction medicine and has served as deputy chairperson and chairperson of the Central Drug Authority of South Africa from 1995 to 2005. World Association for Psychosocial Rehabilitation Secretary General); American Psychiatric Association (International Fellow); South African Society of Psychiatrists (Chair International Relations Division); International Council on Alcohol and Addictions (member); He is chairperson of the Ministerial Advisory Committee on Mental Health in South Africa.
Helen Redmond is a Licensed Clinical Social Worker. She is an expert in addiction and works with drug users and people with a psychiatric diagnosis. Helen provides consultation and training in tobacco harm reduction. Her goal is to help the most marginalized smokers transition to e-cigarettes. She is an independent journalist and has written about drug policy, drug treatment and the American criminal justice system for Al Jazeera, Alternet, Harpers and The Influence. Helen is a filmmaker and she made a short documentary about people with serious mental health problems and smoking. Her documentary,Ezra Dowery: Life on Broadway, was an official selection of the NYC Mental Health Film Festival, 2016.
Louise Ross is the leader of the Leicester City Stop Smoking Service. Louise finished a very happy and long working life in learning disabilities to work in tobacco control and smoking cessation, and has been delighted to discover a second career that has been even more satisfying than the first. Initially sceptical about ecigs, she has become a vocal advocate for their use as a harm reduction method, principally because she has listened to people who have used them to stop smoking, and has been utterly convinced by their sincerity. Louise is an associate of the New Nicotine Alliance UK, a charity committed to improving public health through a greater understanding of risk-reduced nicotine products.
Dr Lion Shahab is a senior lecturer in health psychology at University College London and trained in psychology, epidemiology and neuroscience. He has more than 10 years’ experience in tobacco control with a particular interest in novel behavioural and pharmacological smoking cessation interventions,biomarkers, tobacco product regulation and policy and tobacco use epidemiology. Dr Shahab's research spans a variety of techniques and methods, involving both human (randomised controlled trials, survey analysis, laboratory and experimental work) and animal studies (electrophysiology). He has collaborated with academic as well as non-academic (e.g. governmental and non-governmental) partners and to date has authored over 70 scientific papers and reviews.
Harry Shapiro is Director of DrugWise an online drug information service and managing editor of DS Daily - an online news service on drugs, alcohol and tobacco. He is an author, journalist and lecturer who has written widely on the subject of drugs. He is the author of several books relating to drugs and popular music including Waiting for the Man: the story of drugs and popular music; Shooting Stars: drugs, Hollywood and the movies; Jimi Hendrix, Electric Gypsy; Eric Clapton: Lost in the Blues and Jack Bruce: Composing Himself : the Authorised Biography.
Rajesh N. Sharan, Ph. D., is a Professor at Department of Biochemistry and Director of Design Innovation Center at North-Eastern Hill University, Shillong (India). Rajesh is a Molecular Biologist and Biochemist by training with over 3 decades of research experience in the field of betel (Areca) nut & chemical induced carcinogenesis, and molecular mechanisms of radiation induced damage to DNA & its repair with expertise in biomarker discovery for cancer and radiation damage assessment for their clinical applications. Rajesh is a former President of Indian Society for Radiation Biology and currently a member of CRP of IAEA (Vienna). He has over 105 research publications & books, and few patents to his credit. Rajesh serves as an Associate Editor of the Journal of Radiation Research. Since last year, Rajesh has developed keen interest in the field of tobacco harm reduction in India and initiated research in this area.
Prof Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, World Health Organization, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He was a member of the UK National Institute for Health and Clinical Excellence guidelines group on tobacco harm reduction, and is a member of the British Standards Institute working group on e-cigarette standards. He helps organise the Global Forum on Nicotine conference. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and recent past Editor of the International Journal of Drug Policy. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.
Nancy Sutthoff is the Co-founder and Co-Director of Aotearoa Vapers Community Advocacy (AVCA) in New Zealand. AVCA was officially formed in April 2016 to address the rights of vapers in New Zealand in response to the lack of legislation/regulation/guidance from the national level of government, and local councils misapplication of SmokeFree laws towards Vaping. Nancy has a diverse background with degrees in Police Sciences (A.A.S) and Sociology (B.A) she has always, in one way or another, been involved in investigative and advocacy roles, from business analysis of corporate IT systems to research administration at SUNY Stony Brook (New York, USA) to local government relations for the West Boca Community Council (Florida, USA) to youth health and education advocacy (New Zealand). Nancy’s motivation has been, and always will be, to educate people on their options, to support them in their choices and to honour the memory of her mother (who died young of smoking related disease) by standing up for those whose voices are usually not heard, and fighting with them for their rights to self determination, be it their health or otherwise.
David Sweanor is an adjunct professor, Faculty of Law, University of Ottawa, Centre for Health Law, Policy & Ethics, University of Ottawa and a honorary (consultant) assistant professor, University of Nottingham. He has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked with numerous organisations, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization, and currently focuses much of his efforts on risk reduction strategies. He has received both international recognition and prestigious prizes for his work.
Olivier Théraulaz is the chairman of Helvetic Vape, the Swiss association of vapers. Long-time smoker, he learned by chance in 2013 that the Swiss prohibition on vaping products containing nicotine concerned only sales and that importations for personal use was allowed. He immediately switched to vaping and stopped smoking in less than one week without giving up his pleasure. Convinced of the potential of vaping for public health, he started to advocate for the modification of the absurd administrative Swiss rules about vaping and the dissemination of clear and objective information about risk and harm reduction.
Dr Alex Wodak AM is a retired physician who is now President of the Australian Drug Law Reform Foundation. he works full time on drug law reform as a volunteer. Together with colleagues, he started the first needle syringe programme (1986) and the first medically supervised injecting centre (1999) in Australia when both were pre-legal. Dr Wodak was President of the International Harm Reduction Association (1996-2004). He has been interested in tobacco harm reduction since 1992 but only active in THR in recent years. Dr Wodak helped to start the National Drug and Alcohol Research Centre (1987). Conference, Website, Conference Logos and Conference Name © 2014-2016 K•A•C .
Julie Woessner is the National Policy Director and President of the Board of CASAA (The Consumer Advocates for Smoke-free Alternatives Association). CASAA, a nonprofit U.S.-based public health and education NGO, advocates for people who consume, or might in the future consume, low-risk alternatives to cigarettes. CASAA engages in policy advocacy in the U.S. involving legislative and regulatory matters to protect access to low-risk products and mobilizes its 200,000+ members to do the same. Internationally, CASAA provides education about tobacco harm reduction and advocacy. Woessner holds a JD from Duke School of Law and was previously a practicing attorney.